Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating a combined therapy for patients recovering from post intensive care syndrome after ischemic stroke

Official title: Evaluation of the Efficacy of Permanent Course Combined Therapy With CYTOFLAVIN® Intravenous Solution and CYTOFLAVIN® Tablets, at 2-3 Stages of Rehabilitation of Patients With Post Intensive Care Syndrome

Run by POLYSAN Scientific & Technological Pharmaceutical Company · NCT06735898 · Data updated 2026-11-12

This study is testing a new combined therapy to help people recovering from post intensive care syndrome after an ischemic stroke feel better during their rehabilitation.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment90 (estimated)
SponsorPOLYSAN Scientific & Technological Pharmaceutical Company
Industry-sponsored
Locations1 site (Yekaterinburg, Sverdlovsk Oblast)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedDecember 1, 2025
Study endsMay 1, 2026
Registry record updatedApril 6, 2025
Trial IDNCT06735898 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 who have been in intensive care for at least three days and have a diagnosis of moderate-to-severe post intensive care syndrome.

Probably not a fit

Patients with acute organ failures or those with a premorbid level of vital activity assessed as 4-5 points may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on patients who have experienced post intensive care syndrome (PIC syndrome) following an ischemic stroke. It aims to evaluate the efficacy of a combined therapy using CYTOFLAVIN® intravenous solution and tablets during the rehabilitation process. The approach emphasizes early rehabilitation interventions to address cognitive, motor, and emotional disorders that arise from prolonged intensive care. The study will include patients who have been in intensive care for at least three days and have moderate-to-severe PIC syndrome.

Why it matters

Potential benefit: If successful, this therapy could significantly improve recovery outcomes for patients suffering from post intensive care syndrome.

How similar studies have gone: While the specific combination therapy is novel, similar rehabilitation approaches have shown promise in improving outcomes for patients with post intensive care syndrome.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women over 18 years of age and older;
* Stay in the ITU and (or) intensive care unit for at least 3 days;
* Diagnosed "post intensive care" syndrome (PIC syndrome) with moderate-to-severe severity \>3\<6 points
* Diagnosed modalities "critical illness polyneuropathy, respiratory neuropathy, dysphagia" of the domain "Neuromuscular complications" of PIC syndrome at 2-3 stages of the rehabilitation route at any value of PICS severity index
* Diagnosed modalities "decreased gravitational gradient, decreased exercise tolerance" in the domain "Vegetative-metabolic complications" at 2-3 stages of the rehabilitation route at any value of PICS severity index

Exclusion Criteria:

* Premorbid level of vital activity when assessed on the rehabilitation routing scale 4-5 points;
* Hematocrit ≤30%;
* Hemoglobin level ≤80 g/L;
* Acute cardiac failure;
* Acute respiratory failure;
* Acute renal failure;
* Acute liver cell failure;
* Use of drugs from "metabolic agents" pharmacotherapeutic group at the time of inclusion in the study
* Life expectancy of 6 months or less or presence of incurable diseases in decompensation stage

Where it's running

  • Brain Institute Clinic
    Yekaterinburg, Sverdlovsk Oblast, Russia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

    This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

    Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

  • Remote ischemic conditioning for post-stroke insomnia

    A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.

    Recruiting Sichuan Academy of Medical Sciences · Chengdu, Sichuan · NCT07874594

  • Ear-based nerve stimulation to help sleep after a stroke

    A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.

    Recruiting Casa Colina Hospital and Centers for Healthcare · Pomona, California · NCT07858656

  • Theta Burst Stimulation to Help Stroke Recovery (Upper and Lower Limbs)

    This trial tests whether applying theta burst stimulation to the motor cortex, in combination with standard rehabilitation, helps people over 45 who recently had a first ischemic stroke recover arm and leg movement.

    Recruiting Ankara Etlik City Hospital · Ankara, Yenimahalle · NCT07834333

  • Preventing another ischemic stroke with a smart bracelet and app

    This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.

    Recruiting Affiliated Hospital of Nantong University · Nantong, Jiangsu · NCT07825311

  • Photon-counting CT to check intracranial stents

    This study tests whether ultra-high-resolution photon-counting CT can reliably visualize intracranial stents and detect in-stent restenosis during follow-up of patients with prior stents.

    Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07769814

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.